| Financial Year |
March 31 2023 |
| Monetary Funds |
6,490,353,795.74 |
| Held-for-trading Financial Assets |
1,955,964,508.61 |
| Notes Receivable |
-- |
| Accounts Receivable |
100,109,652.94 |
| Advances to Suppliers |
16,067,292.31 |
| Other Receivables |
33,843,131.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
44,183.09 |
| Dividend Receivable |
-- |
| Inventories |
3,653,832,991.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
369,639.59 |
| Total Current Assets |
12,275,455,320.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,412,978.53 |
| Investment Properties |
-- |
| Fixed Assetes |
1,230,843,951.85 |
| Under-construction Projects |
1,936,220,643.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
376,127,475.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,270,925.51 |
| Deferred Income Tax Assets |
714,137,719.76 |
| Other Non-Current Assets |
3,919,503.29 |
| Sub-Total of Non-Current Assets |
6,706,557,768.88 |
| Total Assets |
18,982,013,089.55 |
| Short-Term Loans |
800,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
383,050,000.00 |
| Accounts Payable |
607,167,285.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
104,967,001.54 |
| Taxes Payable |
984,537,356.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,306,420,321.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
250,067.79 |
| Other Current Liabilities |
148,609,879.53 |
| Sub-Total of Current Liabilities |
6,478,154,832.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
180,345,327.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
184,095,327.49 |
| Total Liabilities |
6,662,250,159.70 |
| Paid-In Capital(Or Share Stock) |
1,254,500,000.00 |
| Capital Surplus |
718,685,433.95 |
| Surplus Reserve |
627,250,000.00 |
| LESS:Treasury Stock |
433,297,016.89 |
| Undistributed Profits |
10,134,024,779.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,319,762,929.85 |
| Owner's Equity（Stockholder's Equity） |
12,319,762,929.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,982,013,089.55 |
